cefaclor anhydrous has been researched along with Bacterial Disease in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 48 (53.93) | 18.7374 |
1990's | 36 (40.45) | 18.2507 |
2000's | 3 (3.37) | 29.6817 |
2010's | 1 (1.12) | 24.3611 |
2020's | 1 (1.12) | 2.80 |
Authors | Studies |
---|---|
Alper Öztürk, A; Aygül, A; Namlı, İ | 1 |
Horvat, O; Mikov, M; Sabo, A; Tomas, A; Tomić, N; Tomić, Z; Vukmirović, S | 1 |
Abe, T; Fukuoka, T; Ito, K; Sato, Y; Sei, M | 1 |
de la Peña, A; Derendorf, H; Gräbe, A; Gross, J; Müller, M; Rand, KH; Rehak, E; Thyroff-Friesinger, U | 1 |
Gormley, IP; Grant, M; Harkness, RA; Kowolik, MJ; Raeburn, JA; Sutherland, R | 1 |
Hodson, ME; Holt, HA; Law, MR; Reeves, DS | 1 |
van Saene, HK; Willems, FT; Zweens, J | 1 |
Pien, FD | 1 |
Horii, M; Morinaga, T; Nishimura, T; Noshi, Y; Okada, T; Sasaki, T; Shimada, S; Takada, S; Takeuchi, T; Yamanaka, H | 1 |
Aten, EM; Parish, LC | 1 |
Fujita, K; Horie, N; Katsumata, M; Kukita, A; Nakano, M; Nonami, E; Shishiba, T; Someya, T; Watanabe, R; Watanabe, S | 1 |
Fujimori, I; Hiraga, Y; Kikuchi, K; Kobayashi, Y; Nakayama, I; Obana, M; Saito, A; Takebe, K; Tomizawa, M; Yamamoto, A | 1 |
Goto, S; Kamimura, T; Kojo, H; Kuwahara, S; Matsumoto, Y; Mine, Y | 1 |
Anari, M; Edén, T; Ernstson, S; Sundberg, L | 1 |
Iancu, TC; Sinoff, G | 1 |
Fukuta, N; Kanematsu, N; Kawata, K; Kita, T; Sato, J; Sato, K; Yoshida, Y | 1 |
Cathlin, C; Lambert-Zechovsky, N; Leveque, B | 1 |
Fujii, R | 2 |
Bucholz, RW; Kusmiesz, H; Nelson, JD; Shelton, S | 1 |
Smialowicz, CR | 1 |
Chin, KC; Cockburn, F; Kerr, MM; McAllister, TA | 1 |
Ginsburg, CM; McCracken, GH | 1 |
Blumer, JL; Deabate, CA; Kafetzis, DA; Mclinn, SE; Perrotta, RJ; Salgado, O | 1 |
Köhler, W; Schenk, P | 1 |
Ball, P | 1 |
Kafetzis, DA | 1 |
Nolen, T | 1 |
Shiba, K; Sunakawa, K | 1 |
Nicolau, DP; Nightingale, CH; Onyeji, CO; Quintiliani, R | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Yokota, N | 1 |
Bergamini, G; Cantini, L; Dallari, S; Galetti, G; Ghidini, A; Martini, A; Mazzoli, M; Monici Preti, PA | 1 |
Vetter, N; Waardenburg, FA; Wettengel, R | 1 |
Drehobl, M; Pien, F; Stevens, DL | 1 |
McCabe, R; Mogabgab, W; Perrotta, R; Rumans, L | 1 |
Li, G; Wu, J; Zhang, Y | 1 |
Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
Hoover, J | 1 |
Brumfitt, W; Hamilton-Miller, JM | 1 |
Allen, BS; Bandak, SI; Bolzon, LD; Henle, SK; Johns, D; Turnak, MR | 1 |
Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
Aqil, S; Bukhari, KA; Gaba, I; Hassan, M; Hassan, S; Iqbal, A; Khan, MK; Khawar, N; Malik, BA; Malik, S; Masood, T; Najam, Y; Sharif, MW; Tarar, MA; Walla, FL | 1 |
Preston, DA | 2 |
Crossley, K; Rotschafer, J; Viste, R; Zaske, D | 1 |
Neu, HC | 1 |
Kammer, RB; Short, LJ | 2 |
Böhmer, R | 1 |
Biolcati, AH | 1 |
Arias, G; Bolaños, HJ; Faingezicht, I; Guevara, J; Ruiz, M | 1 |
Hatakeyama, K; Hori, M; Nakano, K; Sakaguchi, N; Sugita, M; Toyonaga, Y; Yamazaki, M; Yamori, K | 1 |
Paloheimo, SH; Pukander, JS; Sipilä, MM | 1 |
Delacourt, C; Paupe, J; Sarbeji, M; Scheinmann, P; Sorin, M | 1 |
Jacobson, KD; McCarty, J; Ruoff, GE | 1 |
Kinasewitz, G; Wood, RG | 1 |
Clague, JE; Davies, RJ; Herdman, MJ; Tabaqchali, S; Trigg, CJ; Wilks, M | 1 |
Fukuoka, F; Hara, H; Kaneko, A; Michi, K; Morihana, T; Ohne, M; Sasaki, I; Satoh, T; Takahashi, K; Yoshinari, N | 1 |
Lionell, C; Magni, L | 1 |
Hyslop, DL; Oberlin, JA | 1 |
Eliasson, I; Holst, E; Kamme, C; Mölstad, S | 1 |
Buchanan, GR; Morrison, RA; Rogers, ZR; Vedro, DA | 1 |
Guttenplan, M; Handler, SD; Jones, J; Marsh, R; Potsic, W; Tom, LW; Wetmore, R | 1 |
Hanawa, S; Kawanami, T; Morishima, T; Shibata, A | 1 |
Arakawa, S; Hamami, G; Hirooka, K; Ishigami, J; Kamidono, S; Matsumoto, O; Sugimoto, M; Takagi, S; Umezu, K; Yamanaka, N | 1 |
Arakawa, S; Hamami, G; Hirooka, K; Ishigami, J; Kamidono, S; Matsumoto, H; Matsumoto, O; Saito, H; Takagi, S; Umezu, K | 1 |
Gomi, K; Hiraga, Y; Konishi, K; Nakayama, I; Ohmichi, M; Oizumi, K; Saito, A; Tamura, M; Tomizawa, M; Watanabe, A | 1 |
Cocchetto, DM; Gwaltney, JM; Scheld, WM; Sydnor, A | 1 |
Hirata, T; Matsukuma, I; Mochida, K; Okachi, R; Sato, K | 1 |
Iino, Y; Ikeda, M; Ishitoya, J; Ito, Y; Kawashiro, N; Nagahama, T; Nagahara, K; Takahashi, K; Usami, M; Watanabe, K | 1 |
Abbatangelo, R; Cavani, E; Mascelloni, R; Prete, C | 1 |
Verhoef, J | 1 |
Ishikawa, K; Ito, T; Kawai, S; Kobayashi, H; Nakayama, I; Saito, A; Takeuchi, K; Tamura, M; Tomizawa, M; Yajima, O | 1 |
Miyahara, T; Nakayama, I; Onodera, S; Saito, A; Sasaki, N; Shiba, K; Shimada, J; Tamura, M; Tomizawa, M | 1 |
Kamimura, T; Kikuchi, H; Kuwahara, S; Mine, Y; Shibayama, F; Tawara, S; Wakai, Y; Yokota, Y | 1 |
Lin, SR; Peng, CF | 1 |
Hyslop, DL | 1 |
Anthony, WC; Craig, W; File, TM; Lifland, P; Schleupner, CJ; Tan, J; Vogelman, B | 1 |
Ekedahl, C | 1 |
Hamana, Y; Inoue, M; Mitsuhashi, S; Okamoto, S | 1 |
Ando, S; Hirano, M; Kawaguchi, H; Kondo, S; Masuyoshi, S; Miyaki, T; Tomatsu, K | 1 |
Chimoto, T; Ikeda, Y; Ishii, Y; Nakabayashi, T; Onodera, S; Sasaki, N; Shibaki, H; Shimizu, T; Tosaka, M; Watanabe, H | 1 |
Abe, M; Itoh, C; Kikuiri, T; Kurihara, Y; Murakami, T; Nishihara, H; Oshima, S; Shimizu, T; Takeuchi, K; Yokoyama, Y | 1 |
Bonner, DP; Clark, JM; Dalvi, M; Olsen, SJ; Sykes, RB; Weinberg, DS; Whitney, RR | 1 |
Horii, M; Inaba, O; Kimura, J; Nishimura, T; Noshi, Y; Okada, T; Sasaki, T; Shimada, S; Takada, S; Yamanaka, H | 1 |
Doi, S; Fujimoto, M; Ishikawa, S; Kobe, A; Sakai, K; Shibata, Y; Shinagawa, N; Tachi, Y; Ueda, T; Yura, J | 1 |
Hori, M; Kurosu, Y; Nakamura, H; Sugita, M; Toyonaga, Y | 1 |
Ballantyne, FN | 1 |
Baba, S; Furuta, S; Katsuta, K; Kinoshita, H; Mori, Y; Noboru, T; Ohno, I; Ohyama, M; Suzuki, K; Yamamoto, M | 1 |
7 review(s) available for cefaclor anhydrous and Bacterial Disease
Article | Year |
---|---|
[Review [new antibiotics series V]: cefaclor (author's transl)].
Topics: Administration, Oral; Adult; Animals; Bacterial Infections; Cefaclor; Cephalexin; Child, Preschool; Clinical Trials as Topic; Dogs; Double-Blind Method; Guinea Pigs; Humans; Mice; Rabbits; Rats | 1982 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 1994 |
[Reevaluation of current antimicrobials. Cefaclor].
Topics: Adult; Bacterial Infections; Cefaclor; Child; Child, Preschool; Cost-Benefit Analysis; Female; Humans; Male; Microbial Sensitivity Tests | 1994 |
Cefaclor into the millennium.
Topics: Bacterial Infections; Bronchitis; Cefaclor; Cephalosporins; Economics, Pharmaceutical; Ecosystem; Humans; Microbial Sensitivity Tests; Patient Compliance | 1999 |
Cefaclor in the treatment of skin, soft tissue, and urinary tract infections: a review.
Topics: Bacterial Infections; Cefaclor; Cephalexin; Humans; Skin Diseases, Infectious; Urinary Tract Infections | 1988 |
46 trial(s) available for cefaclor anhydrous and Bacterial Disease
Article | Year |
---|---|
Effect of two antibiotics on human granulocyte activities.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Blood Bactericidal Activity; Cefaclor; Female; Granulocytes; Humans; Male; Neutrophils; Peroxidase; Phagocytosis; Recurrence | 1983 |
Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis.
Topics: Aged; Amoxicillin; Bacterial Infections; Bronchitis; Cefaclor; Cephalexin; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Sputum; Time Factors | 1983 |
Influence of amoxycillin and cefaclor on the colonization resistance of oropharynx.
Topics: Adolescent; Amoxicillin; Bacteria; Bacterial Infections; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Humans; Oropharynx; Respiratory Tract Infections | 1983 |
Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.
Topics: Adult; Amoxicillin; Bacterial Infections; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans | 1983 |
[A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
Topics: Adult; Aged; Bacterial Infections; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Jaw Diseases; Male; Middle Aged; Periodontitis | 1984 |
Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cephalexin; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Male; Penicillin Resistance; Skin Diseases, Infectious | 1984 |
[Comparative clinical study of DL-8280 and cefaclor for suppurative skin and soft tissue infections by a double-blind method].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Skin Diseases, Infectious; Suppuration | 1984 |
[Comparative clinical study of ofloxacin and cefaclor in bacterial bronchitis].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines | 1984 |
[Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
Topics: Bacterial Infections; Cefaclor; Cephalexin; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Infant, Newborn; Male; Respiratory Tract Infections | 1980 |
[Review [new antibiotics series V]: cefaclor (author's transl)].
Topics: Administration, Oral; Adult; Animals; Bacterial Infections; Cefaclor; Cephalexin; Child, Preschool; Clinical Trials as Topic; Dogs; Double-Blind Method; Guinea Pigs; Humans; Mice; Rabbits; Rats | 1982 |
Clinical and bacteriological evaluation of cefaclor and tetracycline in acute episodes of bacterial bronchitis.
Topics: Bacterial Infections; Bronchitis; Cefaclor; Cephalexin; Humans; Microbial Sensitivity Tests; Tetracycline | 1982 |
Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group.
Topics: Acute Disease; Adolescent; Bacterial Infections; Cefaclor; Ceftibuten; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media with Effusion; Prospective Studies; Single-Blind Method; Treatment Outcome | 1995 |
[Cephalosporin treatment of maxillary sinusitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cephalosporins; Double-Blind Method; Female; Haemophilus Infections; Humans; Male; Maxillary Sinusitis; Middle Aged; Prodrugs | 1995 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Efficacy and tolerability of brodimoprim in bacterial otitis media in children. Controlled study versus cefaclor.
Topics: Acute Disease; Bacterial Infections; Cefaclor; Child; Child, Preschool; Female; Humans; Male; Otitis Media; Otitis Media with Effusion; Trimethoprim | 1993 |
Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Cefaclor; Clarithromycin; Double-Blind Method; Female; Humans; Male; Middle Aged | 1993 |
Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.
Topics: Administration, Oral; Adult; Bacterial Infections; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Connective Tissue Diseases; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Prodrugs; Safety; Skin Diseases, Bacterial; Staphylococcal Infections | 1993 |
[A randomized control study on the treatment of 123 cases of bacterial infections with cefteram and cefaclor].
Topics: Bacterial Infections; Bronchitis; Cefaclor; Cefmenoxime; Cephalosporins; Cystitis; Humans; Tonsillitis | 1995 |
Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Single-Blind Method | 1999 |
The efficacy and safety of cefaclor in respiratory infections amongst Pakistani children.
Topics: Bacterial Infections; Cefaclor; Cephalosporins; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Treatment Outcome | 2000 |
Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection.
Topics: Amoxicillin; Bacterial Infections; Cefaclor; Cephalexin; Cephradine; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Proteus Infections; Proteus mirabilis; Recurrence; Urinary Tract Infections | 1979 |
An open comparative study of the efficacy and safety of sultamicillin versus cefaclor in the treatment of acute otitis media in children.
Topics: Acute Disease; Administration, Oral; Ampicillin; Bacterial Infections; Cefaclor; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Sulbactam | 1992 |
Comparative study of cefprozil and cefaclor in children with bacterial infections of skin and skin structures.
Topics: Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Prospective Studies; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes | 1992 |
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
Cefetamet pivoxil in pediatric otitis media.
Topics: Acute Disease; Administration, Oral; Bacterial Infections; Cefaclor; Ceftizoxime; Child; Child, Preschool; Humans; Infant; Otitis Media; Treatment Outcome | 1992 |
Clinical trials on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil.
Topics: Bacterial Infections; Bronchitis; Bronchopneumonia; Cefaclor; Ceftizoxime; Child; Child, Preschool; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections | 1992 |
Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cephalosporins; Child; Double-Blind Method; Gastrointestinal Diseases; Headache; Humans; Incidence; Middle Aged; Skin Diseases, Infectious; Treatment Outcome | 1992 |
Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Cefaclor; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia | 1991 |
A double-blind comparison of the effects of cefaclor and amoxycillin on respiratory tract and oropharyngeal flora and clinical response in acute exacerbations of bronchitis.
Topics: Acute Disease; Aged; Aged, 80 and over; Amoxicillin; Bacterial Infections; Bronchitis; Candida; Cefaclor; Double-Blind Method; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Opportunistic Infections; Oropharynx; Sputum | 1991 |
[Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefaclor; Cefuroxime; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Jaw Diseases; Male; Middle Aged; Pericoronitis; Periodontitis; Prodrugs | 1990 |
Emergence and persistence of beta-lactamase-producing bacteria in the upper respiratory tract in children treated with beta-lactam antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Cefaclor; Child; Child, Preschool; Humans; Infant; Penicillin V; Random Allocation; Respiratory Tract Infections | 1990 |
The efficacy of cefaclor vs amoxicillin on recovery after tonsillectomy in children.
Topics: Amoxicillin; Ampicillin; Bacterial Infections; Cefaclor; Cefazolin; Cephalexin; Child; Female; Humans; Male; Postoperative Care; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors; Tonsillectomy | 1990 |
[Clinical study of S 6472 in urinary tract infection].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1990 |
[A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Double-Blind Method; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1990 |
[Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia | 1990 |
[Factors on delayed recovery of otitis media with effusion in children--clinical and bacteriological study].
Topics: Adolescent; Bacteria; Bacterial Infections; Cefaclor; Child; Child, Preschool; Female; Humans; Infant; Japan; Male; Multicenter Studies as Topic; Otitis Media with Effusion | 1989 |
[Comparative clinical study of T-2588 and cefaclor in chronic respiratory tract infections by a double-blind method].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cefmenoxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1986 |
[Comparative clinical study of CS-807 and cefaclor for bacterial pneumonia by a double-blind method].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia | 1988 |
Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Bacterial Infections; Bronchitis; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Drug Therapy; Female; Humans; Male; Middle Aged; Pneumonia; Prodrugs; Random Allocation; Respiratory Tract Infections | 1988 |
[Acute sinusitis in adults].
Topics: Acute Disease; Adult; Bacterial Infections; Cefaclor; Doxycycline; Haemophilus Infections; Haemophilus influenzae; Humans; Pneumococcal Infections; Sinusitis; Streptococcus pneumoniae | 1987 |
[A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin, in the treatment of bacterial pneumonia].
Topics: Adolescent; Adult; Aged; Amoxicillin; Bacterial Infections; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lung Abscess; Male; Middle Aged; Pneumonia | 1986 |
[A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
Topics: Adult; Aged; Bacterial Infections; Bronchitis; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged | 1986 |
[Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefaclor; Cephalexin; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Mouth Diseases | 1985 |
[Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
Topics: Administration, Oral; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefaclor; Cephalexin; Child; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged | 1985 |
Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections.
Topics: Adult; Bacterial Infections; Cefaclor; Cefadroxil; Cephalexin; Female; Humans; Male; Random Allocation; Skin Diseases, Infectious | 1985 |
39 other study(ies) available for cefaclor anhydrous and Bacterial Disease
Article | Year |
---|---|
Cefaclor Monohydrate-Loaded Colon-Targeted Nanoparticles for Use in COVID-19 Dependent Coinfections and Intestinal Symptoms: Formulation, Characterization, Release Kinetics, and Antimicrobial Activity.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Coinfection; COVID-19; Drug Compounding; Escherichia coli; Excipients; Intestinal Diseases; Kinetics; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids; Staphylococcus aureus | 2021 |
Do We Bury Antibacterials When Launching? Cefaclor Example.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections; Young Adult | 2016 |
[Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Drug Resistance, Bacterial; Humans; Japan; Product Surveillance, Postmarketing; Time Factors | 2002 |
PK-PD modelling of the effect of cefaclor on four different bacterial strains.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefaclor; Culture Media; Drug Stability; Escherichia coli; Haemophilus influenzae; Humans; In Vitro Techniques; Models, Biological; Moraxella catarrhalis; Streptococcus pneumoniae | 2004 |
In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
Topics: Amoxicillin; Animals; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cefaclor; Cefixime; Cephalexin; Cephalosporins; Mice; Penicillin Resistance | 1984 |
Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media.
Topics: Adenoids; Adolescent; Adult; Bacterial Infections; Cefaclor; Cephalexin; Child; Child, Preschool; Ear, Middle; Exudates and Transudates; Humans; Infant; Kinetics; Middle Aged; Otitis Media; Otitis Media with Effusion; Premedication | 1983 |
Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
Topics: Acute Disease; Bacterial Infections; Cefaclor; Cephalexin; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media; Pneumonia; Respiratory Tract Infections | 1983 |
[Clinical results of cefaclor treatment of infections of oral regions].
Topics: Administration, Oral; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefaclor; Cephalexin; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Mouth Diseases | 1984 |
Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections.
Topics: Acute Disease; Administration, Oral; Arthritis, Infectious; Bacterial Infections; Cefaclor; Cefamandole; Cefuroxime; Cephalexin; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Parenteral; Male; Osteoarthritis; Osteomyelitis; Suppuration | 1982 |
A pharmacological study of cefaclor in the newborn infant.
Topics: Bacterial Infections; Cefaclor; Cephalexin; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intestinal Absorption; Kinetics; Pregnancy | 1981 |
Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics.
Topics: Adolescent; Bacterial Infections; Cefaclor; Cephalexin; Humans; Infant; Otitis Media; Penicillins; Skin Diseases, Infectious; Tonsillitis; Urinary Tract Infections | 1980 |
Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; Cefaclor; Ceftibuten; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Mice; Time Factors | 1994 |
[Antimicrobial activities of cefteram against recently clinically detected and isolated strains from patients with dental infections].
Topics: Ampicillin; Bacterial Infections; Bacteroides; Cefaclor; Cefmenoxime; Drug Resistance, Microbial; Eubacterium; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactococcus; Mouth Diseases; Peptostreptococcus; Porphyromonas; Streptococcus; Veillonella | 1994 |
Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Bronchiectasis; Cefaclor; Ceftibuten; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia | 1993 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
"Antibiotic selection for endodontic infections".
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cephalexin; Clindamycin; Dental Pulp Cavity; Dental Pulp Diseases; Erythromycin; Humans; Patient Care Planning; Penicillin V; Periapical Diseases | 1995 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
Summary of laboratory studies on the antibacterial activity of cefaclor.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamases; Cefaclor; Cephalexin; Cephalothin; Drug Evaluation; Drug Stability; Enterobacteriaceae; Haemophilus; Methods; Mice; Microbial Sensitivity Tests; Streptococcus pneumoniae | 1979 |
Summary of laboratory studies on the antibacterial activity of cefaclor.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamases; Cefaclor; Cephalexin; Cephalothin; Culture Media; Drug Stability; Escherichia coli; Haemophilus influenzae; Mice; Microbial Sensitivity Tests | 1979 |
Laboratory and clinical studies of cefaclor in Japan.
Topics: Adult; Bacteria; Bacterial Infections; Cefaclor; Cephalexin; Child; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Staphylococcus aureus | 1979 |
Clinical advances in oral antibiotic therapy. Summary and closing remarks.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cefaclor; Cephalexin; Child; Child, Preschool; Humans; Infant | 1979 |
Cefaclor--summary of clinical experience.
Topics: Adult; Bacteria; Bacterial Infections; Cefaclor; Cephalexin; Child; Humans; Otitis Media; Pharyngitis; Respiratory Tract Infections; Skin Diseases, Infectious; Streptococcal Infections; Urinary Tract Infections | 1979 |
[Therapy of bronchitis and bronchopneumonia in adults with cefaclor (author's transl)].
Topics: Adult; Aged; Bacterial Infections; Bronchitis; Bronchopneumonia; Cefaclor; Cephalexin; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged | 1979 |
Cefaclor: summary of clinical experience.
Topics: Adult; Bacterial Infections; Cefaclor; Cephalexin; Child; Drug Evaluation; Drug Hypersensitivity; Gastrointestinal Diseases; Humans; Otitis Media; Respiratory Tract Infections; Skin Diseases, Infectious; Streptococcal Infections; Urinary Tract Infections | 1979 |
In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
Topics: Absorption; Animals; Bacterial Infections; Cefaclor; Cephalosporins; Disease Models, Animal; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Prodrugs; Staphylococcal Infections | 1990 |
Cefaclor treatment of upper and lower respiratory tract infections caused by Moraxella catarrhalis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefaclor; Cephalexin; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Moraxella catarrhalis; Respiratory Tract Infections; Retrospective Studies | 1990 |
Outpatient management of febrile illness in infants and young children with sickle cell anemia.
Topics: Age Factors; Anemia, Sickle Cell; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; Cefaclor; Ceftriaxone; Cefuroxime; Child, Preschool; Cost-Benefit Analysis; Female; Fever; Humans; Infant; Infant, Newborn; Male; Outpatients; Penicillins | 1990 |
[A clinical study on S6472, sustained release preparation of cefaclor, dermatological area].
Topics: Administration, Oral; Adolescent; Adult; Bacteria; Bacterial Infections; Cefaclor; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Male; Middle Aged; Skin Diseases, Infectious | 1990 |
Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; beta-Lactamases; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Drug Evaluation; Female; Haemophilus influenzae; Humans; Male; Maxillary Sinusitis; Middle Aged; Moraxella catarrhalis; Prodrugs; Streptococcus pneumoniae | 1989 |
In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem.
Topics: Administration, Oral; Animals; Bacterial Infections; Cefaclor; Cephalexin; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests | 1989 |
[Use of cefaclor monohydrate in infections of the upper and lower respiratory tract].
Topics: Adult; Aged; Bacterial Infections; Bronchitis; Cefaclor; Cephalexin; Drug Evaluation; Female; Humans; Laryngitis; Male; Middle Aged; Tracheitis | 1988 |
In vivo antibacterial activity of FK482, a new orally active cephalosporin.
Topics: Administration, Oral; Animals; Bacterial Infections; Cefaclor; Cefdinir; Cephalosporins; Male; Mice; Mice, Inbred ICR; Pneumonia; Pyelonephritis; Rabbits | 1988 |
In vitro antibacterial activity of cefixime.
Topics: Amoxicillin; Ampicillin; Bacteria; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Humans; Microbial Sensitivity Tests | 1988 |
Cefaclor safety profile: a ten-year review.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefaclor; Cephalexin; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Middle Aged | 1988 |
In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefaclor; Cefmenoxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Hexosyltransferases; Male; Mice; Mice, Inbred ICR; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding | 1987 |
In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
Topics: Animals; Bacteria, Aerobic; Bacterial Infections; beta-Lactamases; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Mice; Microbial Sensitivity Tests; Rats | 1987 |
In vivo evaluation of tigemonam, a novel oral monobactam.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Animals; Bacterial Infections; Cefaclor; Cephalexin; Dogs; Enterobacteriaceae Infections; Female; Kinetics; Klebsiella pneumoniae; Male; Mice; Monobactams; Pneumonia; Pyelonephritis; Rats; Rats, Inbred Strains | 1987 |
[Fundamental and clinical studies of S 6472 (sustained release preparation of cefaclor) in the pediatric field].
Topics: Administration, Oral; Bacterial Infections; Bronchitis; Bronchopneumonia; Cefaclor; Cephalexin; Child; Child, Preschool; Delayed-Action Preparations; Drug Evaluation; Drug Resistance, Microbial; Female; Haemophilus influenzae; Humans; Kinetics; Male; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Tonsillitis | 1985 |
[Clinical studies of S6472 in otorhinolaryngologic infections].
Topics: Administration, Oral; Adolescent; Adult; Aged; Bacterial Infections; Cefaclor; Cephalexin; Child; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Male; Middle Aged; Otorhinolaryngologic Diseases | 1985 |